Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

RavenQuest BioMed Inc. RVVQF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
30/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

RavenQuest BioMed Inc. (RVVQF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 28/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $1M, +1018.8%/yr average growth. Net income is $30M (loss), growing at -1594.2%/yr. Net profit margin is -2423.9% (negative). Gross margin is 63.7% (+50.7 pp trend).

Balance sheet: total debt is $13M against $22M equity (Debt-to-Equity (D/E) ratio 0.59, moderate). Current ratio is 1.14 (adequate). Debt-to-assets is 35.2%. Total assets: $38M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 33/100 (Fail), Moat 50/100 (Partial), Future ?/100 (Fail), Income 10/100 (Fail).

RVVQF SharesGrow Score Overview

38/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 50/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — RVVQF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
RVVQF: +1018.8%/yr revenue is, -1594.2%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
33/100
Balance sheet RVVQF: Debt-to-Equity (D/E) ratio 0.59 (moderate), Current ratio is 1.14 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
50/100
RVVQF: Gross margin is 63.7% (+50.7 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 50/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
RVVQF: Net profit margin is -2423.9%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.000001-0.00001
Volume65.26K
Avg Volume (30D)29.7K
Market Cap$1.24K
Beta (1Y)-0.23
Share Statistics
EPS (TTM)-0.33
Shares Outstanding$91.03M
IPO Date2018-03-05
CEODavid Allen Cross
Financial Highlights & Ratios
Revenue (TTM)$1.26M
Gross Profit$801.29K
EBITDA$-27.26M
Net Income$-30.47M
Operating Income$-17.18M
Total Cash$362.81K
Total Debt$13.26M
Net Debt$12.9M
Total Assets$37.7M
Price / Earnings (P/E)-0
Price / Sales (P/S)0
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA7543871080

Price Chart

Track all markets on TradingView
RVVQF
RavenQuest BioMed Inc. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.00

People Also View

RAMMF
RAMMF
RAMM Pharma Corp.
$0.06
+0.00%
 PHCG
PHCG
Pure Harvest Corporate Group, Inc.
$0.01
+4.00%
 CVGRF
CVGRF
City View Green Holdings Inc.
$0.03
-4.57%
 SPBBF
SPBBF
Speakeasy Cannabis Club Ltd.
$0.00
+0.00%
 BHHKF
BHHKF
Craftport Cannabis Corp.
$0.00
+0.00%
 CRFTF
CRFTF
BC Craft Supply Co. Ltd.
$0.00
+0.00%
 LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
 JNJ
JNJ
Johnson & Johnson
$238.67
-0.60%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message